{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:30:47Z","timestamp":1790105447955,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Science and Health Joint Medical Research Project","award":["2023MSXM110"],"award-info":[{"award-number":["2023MSXM110"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370483"],"award-info":[{"award-number":["82370483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04763-z","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:18:20Z","timestamp":1745392700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations between new-onset postoperative atrial fibrillation and changes in left ventricular mass index in patients undergoing transcatheter aortic valve replacement"],"prefix":"10.1186","volume":"25","author":[{"given":"Hua-Jie","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Feng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"5","key":"4763_CR1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10741-023-10312-7","volume":"28","author":"M Avvedimento","year":"2023","unstructured":"Avvedimento M, Angellotti D, Ilardi F, Leone A, Scalamogna M, Castiello DS, et al. Acute advanced aortic stenosis. Heart Fail Rev. 2023;28(5):1101\u201311.","journal-title":"Heart Fail Rev"},{"issue":"7","key":"4763_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"18","key":"4763_CR3","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"6","key":"4763_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jcin.2022.01.018","volume":"15","author":"T Ryan","year":"2022","unstructured":"Ryan T, Grindal A, Jinah R, Um KJ, Vadakken ME, Pandey A, et al. New-Onset atrial fibrillation after transcatheter aortic valve replacement: A systematic review and Meta-Analysis. JACC Cardiovasc Interv. 2022;15(6):603\u201313.","journal-title":"JACC Cardiovasc Interv"},{"key":"4763_CR5","doi-asserted-by":"crossref","unstructured":"Brahier MS, Kochi S, Huang J, Piliponis E, Smith A, Johnson A, et al. Machine learning of cardiac anatomy and the risk of New-Onset atrial fibrillation after TAVR. JACC Clin Electrophysiol; 2024.","DOI":"10.1016\/j.jacep.2024.04.006"},{"issue":"1","key":"4763_CR6","doi-asserted-by":"publisher","first-page":"100353","DOI":"10.1016\/j.shj.2024.100353","volume":"9","author":"S Shekhar","year":"2025","unstructured":"Shekhar S, Krishnaswamy A, Reed G, Yun J, Puri R, Kapadia S. Early outcomes with cerebral embolic protection during transcatheter aortic valve replacement in patients with atrial fibrillation. Struct Heart. 2025;9(1):100353.","journal-title":"Struct Heart"},{"issue":"2","key":"4763_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.athoracsur.2024.03.020","volume":"118","author":"JH Mehaffey","year":"2024","unstructured":"Mehaffey JH, Kawsara M, Jagadeesan V, Chauhan D, Hayanga J, Mascio CE, et al. Atrial fibrillation management during surgical vs transcatheter aortic valve replacement. Ann Thorac Surg. 2024;118(2):421\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"4763_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2459\/JCM.0000000000001591","volume":"25","author":"M Metra","year":"2024","unstructured":"Metra M, Radulescu CI, Cersosimo A, Massussi M, Laurito A, Chioncel O, et al. Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence. J Cardiovasc Med (Hagerstown). 2024;25(4):259\u201370.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"4763_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/pace.14944","volume":"47","author":"G Arabia","year":"2024","unstructured":"Arabia G, Bellicini MG, Cersosimo A, Memo M, Mazzarotto F, Inciardi RM, et al. Ion channel dysfunction and fibrosis in atrial fibrillation: two sides of the same coin. Pacing Clin Electrophysiol. 2024;47(3):417\u201328.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"4763_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.hrthm.2018.09.016","volume":"16","author":"JT Kowallick","year":"2019","unstructured":"Kowallick JT, Staab W, Schuster A, Backhaus SJ, Weber-Kruger M, Bauer L, et al. Reverse left ventricular structural remodeling after catheter ablation of atrial fibrillation in patients with preserved left ventricular function: insights from cardiovascular magnetic resonance native T1 mapping. Heart Rhythm. 2019;16(3):424\u201332.","journal-title":"Heart Rhythm"},{"key":"4763_CR11","doi-asserted-by":"crossref","unstructured":"Choi Y, Hwang BH, Oh GC, Kim JJ, Choo E, Kim MC et al. Long-Term maintenance of sinus rhythm is associated with favorable echocardiographic remodeling and improved clinical outcomes after transcatheter aortic valve replacement. J Clin Med 2022, 11(5).","DOI":"10.3390\/jcm11051330"},{"issue":"24","key":"4763_CR12","first-page":"1992","volume":"103","author":"E Minamino-Muta","year":"2017","unstructured":"Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Inoko M, Haruna T, et al. Impact of the left ventricular mass index on the outcomes of severe aortic stenosis. Heart. 2017;103(24):1992\u20139.","journal-title":"Heart"},{"issue":"36","key":"4763_CR13","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"12","key":"4763_CR14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"M Galderisi","year":"2017","unstructured":"Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2017;18(12):1301\u201310.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"4763_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/ajh.2012.109","volume":"25","author":"E Andrikou","year":"2012","unstructured":"Andrikou E, Tsioufis C, Thomopoulos C, Andrikou I, Kasiakogias A, Leontsinis I, et al. Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: a prospective study. Am J Hypertens. 2012;25(11):1195\u2013201.","journal-title":"Am J Hypertens"},{"issue":"9","key":"4763_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/jcu.23585","volume":"51","author":"L Huang","year":"2023","unstructured":"Huang L, Lai X, Xu L, Zeng Z, Xia H. Left ventricular reverse remodeling after transcatheter aortic valve replacement for predominant aortic stenosis and mixed aortic valve disease. J Clin Ultrasound. 2023;51(9):1453\u201360.","journal-title":"J Clin Ultrasound"},{"key":"4763_CR17","doi-asserted-by":"publisher","first-page":"789548","DOI":"10.3389\/fcvm.2021.789548","volume":"8","author":"HK Jeong","year":"2021","unstructured":"Jeong HK, Yoon N, Kim JH, Lee N, Hyun DY, Kim MC, et al. Post-operative atrial fibrillation impacts on outcomes in transcatheter and surgical aortic valve replacement. Front Cardiovasc Med. 2021;8:789548.","journal-title":"Front Cardiovasc Med"},{"key":"4763_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.amjcard.2021.02.040","volume":"148","author":"B Shahim","year":"2021","unstructured":"Shahim B, Malaisrie SC, George I, Thourani VH, Biviano AB, Russo MJ, et al. Atrial fibrillation and outcomes after transcatheter or surgical aortic valve replacement (from the PARTNER 3 Trial). Am J Cardiol. 2021;148:116\u201323.","journal-title":"Am J Cardiol"},{"issue":"17","key":"4763_CR19","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","volume":"11","author":"AN Vora","year":"2018","unstructured":"Vora AN, Dai D, Matsuoka R, Harrison JK, Hughes GT, Sherwood MW, et al. Incidence, management, and associated clinical outcomes of New-Onset atrial fibrillation following transcatheter aortic valve replacement: an analysis from the STS\/ACC TVT registry. JACC Cardiovasc Interv. 2018;11(17):1746\u201356.","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"4763_CR20","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jacc.2013.11.046","volume":"63","author":"T Tanawuttiwat","year":"2014","unstructured":"Tanawuttiwat T, O\u2019Neill BP, Cohen MG, Chinthakanan O, Heldman AW, Martinez CA, et al. New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches. J Am Coll Cardiol. 2014;63(15):1510\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4763_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3349\/ymj.2022.0649","volume":"64","author":"SY Lee","year":"2023","unstructured":"Lee SY, Choi KH, Park TK, Kim J, Kim EK, Park SJ, et al. Impact of atrial fibrillation on patients undergoing transcatheter aortic valve implantation (TAVI): the K-TAVI registry. Yonsei Med J. 2023;64(7):413\u201322.","journal-title":"Yonsei Med J"},{"issue":"6","key":"4763_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ccd.27155","volume":"90","author":"C Hengstenberg","year":"2017","unstructured":"Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mikhail G, Meneveau N, et al. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv. 2017;90(6):1027\u201337.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"4763_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.hrtlng.2019.10.011","volume":"49","author":"R Doshi","year":"2020","unstructured":"Doshi R, Pisipati S, Taha M, Dave M, Shah J, Adalja D, et al. Incidence, 30-day readmission rates and predictors of readmission after new onset atrial fibrillation who underwent transcatheter aortic valve replacement. Heart Lung. 2020;49(2):186\u201392.","journal-title":"Heart Lung"},{"issue":"21","key":"4763_CR24","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.jcin.2019.06.019","volume":"12","author":"A Mentias","year":"2019","unstructured":"Mentias A, Saad M, Girotra S, Desai M, Elbadawi A, Briasoulis A, et al. Impact of Pre-Existing and New-Onset atrial fibrillation on outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12(21):2119\u201329.","journal-title":"JACC Cardiovasc Interv"},{"key":"4763_CR25","doi-asserted-by":"crossref","unstructured":"Angellotti D, Manzo R, Castiello DS, Immobile MM, Mariani A, Iapicca C et al. Echocardiographic evaluation after transcatheter aortic valve implantation: A comprehensive review. Life (Basel) 2023, 13(5).","DOI":"10.3390\/life13051079"},{"issue":"3","key":"4763_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/ERP-20-0009","volume":"7","author":"V Tsampasian","year":"2020","unstructured":"Tsampasian V, Panoulas V, Jabbour RJ, Ruparelia N, Malik IS, Hadjiloizou N, et al. Left ventricular speckle tracking echocardiographic evaluation before and after TAVI. Echo Res Pract. 2020;7(3):29\u201338.","journal-title":"Echo Res Pract"},{"issue":"2","key":"4763_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ehf2.14305","volume":"10","author":"N Ito","year":"2023","unstructured":"Ito N, Zen K, Takahara M, Tani R, Nakamura S, Fujimoto T, et al. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement. ESC Heart Fail. 2023;10(2):1336\u201346.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"4763_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jjcc.2020.12.017","volume":"77","author":"T Tanaka","year":"2021","unstructured":"Tanaka T, Yahagi K, Asami M, Ninomiya K, Kikushima H, Okuno T, et al. Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement. J Cardiol. 2021;77(4):346\u201352.","journal-title":"J Cardiol"},{"issue":"19","key":"4763_CR29","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.jacc.2020.03.042","volume":"75","author":"KH Chau","year":"2020","unstructured":"Chau KH, Douglas PS, Pibarot P, Hahn RT, Khalique OK, Jaber WA, et al. Regression of left ventricular mass after transcatheter aortic valve replacement: the PARTNER trials and registries. J Am Coll Cardiol. 2020;75(19):2446\u201358.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4763_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jelectrocard.2017.02.013","volume":"50","author":"D Zweiker","year":"2017","unstructured":"Zweiker D, Froschl M, Tiede S, Weidinger P, Schmid J, Manninger M, et al. Atrial fibrillation in transcatheter aortic valve implantation patients: incidence, outcome and predictors of new onset. J Electrocardiol. 2017;50(4):402\u20139.","journal-title":"J Electrocardiol"},{"issue":"10","key":"4763_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/14779072.2021.1988852","volume":"19","author":"MZ Khan","year":"2021","unstructured":"Khan MZ, Zahid S, Khan MU, Kichloo A, Jamal S, Minhas A, et al. Outcomes of transcatheter aortic valve replacement in patients with and without atrial fibrillation: insight from National inpatient sample. Expert Rev Cardiovasc Ther. 2021;19(10):939\u201346.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"4763_CR32","doi-asserted-by":"crossref","unstructured":"Geisler D, Rudzinski PN, Hasan W, Andreas M, Hasimbegovic E, Adlbrecht C et al. Identifying patients without a survival benefit following transfemoral and transapical transcatheter aortic valve replacement. J Clin Med 2021, 10(21).","DOI":"10.3390\/jcm10214911"},{"key":"4763_CR33","doi-asserted-by":"crossref","unstructured":"Lip G, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular. Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), 2019;21(2):192\u2013193.","DOI":"10.1093\/europace\/euy174"},{"issue":"6","key":"4763_CR34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.23736\/S2724-5683.24.06546-3","volume":"72","author":"C Lavalle","year":"2024","unstructured":"Lavalle C, Pierucci N, Mariani MV, Piro A, Borrelli A, Grimaldi M, et al. Italian registry in the setting of atrial fibrillation ablation with Rivaroxaban - IRIS. Minerva Cardiol Angiol. 2024;72(6):625\u201337.","journal-title":"Minerva Cardiol Angiol"},{"key":"4763_CR35","doi-asserted-by":"publisher","first-page":"1234368","DOI":"10.3389\/fcvm.2023.1234368","volume":"10","author":"C Basile","year":"2023","unstructured":"Basile C, Mancusi C, Franzone A, Avvedimento M, Bardi L, Angellotti D, et al. Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the effectavi registry. Front Cardiovasc Med. 2023;10:1234368.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"4763_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00392-021-01810-5","volume":"110","author":"J Ledwoch","year":"2021","unstructured":"Ledwoch J, Frohlich C, Olbrich I, Poch F, Thalmann R, Fellner C, et al. Impact of sinus rhythm versus atrial fibrillation on left ventricular remodeling after transcatheter aortic valve replacement. Clin Res Cardiol. 2021;110(5):689\u201398.","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"4763_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10741-018-9752-6","volume":"24","author":"L Garg","year":"2019","unstructured":"Garg L, Gupta M, Sabzwari S, Agrawal S, Agarwal M, Nazir T, et al. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management. Heart Fail Rev. 2019;24(2):189\u201397.","journal-title":"Heart Fail Rev"},{"issue":"23 Suppl 1","key":"4763_CR38","doi-asserted-by":"publisher","first-page":"i21","DOI":"10.1093\/europace\/euaa387","volume":"23","author":"A Lyon","year":"2021","unstructured":"Lyon A, van Mourik M, Cruts L, Heijman J, Bekkers S, Schotten U, et al. Both beat-to-beat changes in RR-interval and left ventricular filling time determine ventricular function during atrial fibrillation. Europace. 2021;23(23 Suppl 1):i21\u20138.","journal-title":"Europace"},{"key":"4763_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijcard.2015.09.032","volume":"202","author":"P Alter","year":"2016","unstructured":"Alter P, Koczulla AR, Nell C, Figiel JH, Vogelmeier CF, Rominger MB. Wall stress determines systolic and diastolic function\u2013Characteristics of heart failure. Int J Cardiol. 2016;202:685\u201393.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4763_CR40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12967-023-04381-3","volume":"21","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhan S, Chen L, Sun M, Li M, Mou X, et al. TNFSF14\/LIGHT promotes cardiac fibrosis and atrial fibrillation vulnerability via PI3Kgamma\/SGK1 pathway-dependent M2 macrophage polarisation. J Transl Med. 2023;21(1):544.","journal-title":"J Transl Med"},{"key":"4763_CR41","doi-asserted-by":"crossref","unstructured":"Noirclerc N, Huttin O, de Chillou C, Selton-Suty C, Fillipetti L, Sellal JM et al. Cardiac remodeling and diastolic dysfunction in paroxysmal atrial fibrillation. J Clin Med 2021, 10(17).","DOI":"10.3390\/jcm10173894"},{"issue":"5","key":"4763_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jjcc.2020.11.007","volume":"77","author":"M Okada","year":"2021","unstructured":"Okada M, Tanaka N, Oka T, Tanaka K, Ninomiya Y, Hirao Y, et al. Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction. J Cardiol. 2021;77(5):500\u20138.","journal-title":"J Cardiol"},{"issue":"20","key":"4763_CR43","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1093\/eurheartj\/ehaa033","volume":"41","author":"M Puls","year":"2020","unstructured":"Puls M, Beuthner BE, Topci R, Vogelgesang A, Bleckmann A, Sitte M, et al. Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis. Eur Heart J. 2020;41(20):1903\u201314.","journal-title":"Eur Heart J"},{"issue":"1","key":"4763_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.amjcard.2019.04.010","volume":"124","author":"C Izumi","year":"2019","unstructured":"Izumi C, Kitai T, Kume T, Onishi T, Yuda S, Hirata K, et al. Effect of left ventricular reverse remodeling on Long-term outcomes after aortic valve replacement. Am J Cardiol. 2019;124(1):105\u201312.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4763_CR45","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4022\/jafib.1437","volume":"10","author":"AB Ross","year":"2017","unstructured":"Ross AB, Katz MG, Williams ZR, Dixen U, Jensen GB, Schwarz KQ. Left ventricular systolic function assessed by global longitudinal strain is impaired in atrial fibrillation compared to sinus rhythm. J Atr Fibrillation. 2017;10(4):1437.","journal-title":"J Atr Fibrillation"},{"issue":"1","key":"4763_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/0115701611264647231110101700","volume":"22","author":"G Koracevic","year":"2024","unstructured":"Koracevic G, Micic S, Stojanovic M, Zdravkovic M, Simic D, Kostic T, et al. Beta-blockers in hypertensive left ventricular hypertrophy and atrial fibrillation prevention. Curr Vasc Pharmacol. 2024;22(1):19\u201327.","journal-title":"Curr Vasc Pharmacol"},{"key":"4763_CR47","doi-asserted-by":"publisher","first-page":"639993","DOI":"10.3389\/fcvm.2021.639993","volume":"8","author":"H Xiang","year":"2021","unstructured":"Xiang H, Xue Y, Chen Z, Yu Y, Peng Y, Wang J, et al. The association between left ventricular hypertrophy and the occurrence and prognosis of atrial fibrillation: A Meta-Analysis. Front Cardiovasc Med. 2021;8:639993.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4763_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1291\/hypres.30.535","volume":"30","author":"MG Hennersdorf","year":"2007","unstructured":"Hennersdorf MG, Schueller PO, Steiner S, Strauer BE. Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension. Hypertens Res. 2007;30(6):535\u201340.","journal-title":"Hypertens Res"},{"issue":"2","key":"4763_CR49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5603\/CJ.a2019.0004","volume":"27","author":"A Lizewska-Springer","year":"2020","unstructured":"Lizewska-Springer A, Dabrowska-Kugacka A, Lewicka E, Krolak T, Drelich L, Kozlowski D, et al. Echocardiographic assessment in patients with atrial fibrillation (AF) and normal systolic left ventricular function before and after catheter ablation: if AF begets AF, does pulmonary vein isolation terminate the vicious circle? Cardiol J. 2020;27(2):126\u201335.","journal-title":"Cardiol J"},{"issue":"4","key":"4763_CR50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jtcvs.2013.05.015","volume":"146","author":"PM Mccarthy","year":"2013","unstructured":"Mccarthy PM, Manjunath A, Kruse J, Andrei AC, Li Z, Mcgee EJ, et al. Should paroxysmal atrial fibrillation be treated during cardiac surgery? J Thorac Cardiovasc Surg. 2013;146(4):810\u201323.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4763_CR51","doi-asserted-by":"crossref","unstructured":"Mariani MV, Lavalle C, Palombi M, Pierucci N, Trivigno S, D\u2019Amato A, et al. SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices. ESC Heart Fail; 2025.","DOI":"10.1002\/ehf2.15223"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04763-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:03:57Z","timestamp":1745395437000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04763-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4763"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04763-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board of Southwest Hospital of Third Military Medical University (approval number: KY20210158) and conducted in accordance with the Declaration of Helsinki (as revised in 2013). The Institutional Review Board of Southwest Hospital of Third Military Medical University waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"306"}}